Alexion Pharmaceuticals Competitors and Similar CompaniesClear all
Alexion Pharmaceuticals's competitors and similar companies include Regeneron Pharmaceuticals, MediWound and Angion Biomedica.
 Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. |  Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. | |
Founding Date | Founding Date 1992 | Founding Date 1988 | Founding Date 2001 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations San Francisco, US HQ Uniondale, US |
Employees | Employees 10,6006% increase | Employees 15,1068% increase | Employees 111 | Employees 205% increase |
Valuation ($) | Valuation ($) 40.3 b | Valuation ($) 102.2 b | Valuation ($) 196.3 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $17m (FY, 2025) | Revenue (est.) $2.3m (FY, 2022) |
Cost of goods | Cost of goods $553.5m (FY, 2020) | Cost of goods N/A | Cost of goods $13.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $5.5b (FY, 2020) | Gross profit N/A | Gross profit $4.1m (FY, 2025) | Gross profit N/A |
Net income | Net income $603.4m (FY, 2020) | Net income $4.5b (FY, 2025) | Net income ($23.9m) (FY, 2025) | Net income ($38.8m) (FY, 2022) |
Operating ⚠ | ||||
Patents (US) | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) 19 (Mar, 2021) |
Products | Products 5 (Q1, 2021) | Products 11 (FY, 2022) | Products N/A | Products N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised $ 19.7m |
For sources of this data, please see the company profile
View Company Profiles
Regeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View companyMediWound
HQ
Yavne, IL
Employees
111
MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
View companyAngion Biomedica
HQ
San Francisco, US
Employees
20↑ 5% increase
Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View company